Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vaishali Pharma Limited Call Transcript 2023

Nov 18, 2023

62707_rns_2023-11-18_10e34699-d1d5-41b6-9dbb-d076ed5e4dae.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [594 x 136] intentionally omitted <==

November 18, 2023

To, The Manager

National Stock Exchange of India Limited Exchange Plaza, 5[th ] Floor, Plot No. C/1, G Block, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051

Stock Code: VAISHALI

SUB: Intimation of Conference Call to discuss earnings of the Company for Q2FY24

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Management team of the Company shall be participating in Q2FY24 earnings call scheduled on Thursday, November 23, 2023 at 4.00 pm (IST) hosted by Kirin Advisors.

Please find attach the details of the invitation.

The aforesaid information is also made available on Company’s website www.vaishalipharma.com .

This is for your information and record.

You are requested to take the same on record.

Thanking you.

Yours faithfully, For Vaishali Pharma Limited,

ATUL ARVIND Digitally signed by ATUL ARVIND VASANI DN: c=IN, postalCode=400092, st=MAHARASHTRA, street=MUMBAI, l=MUMBAI, o=Personal, serialNumber=35914012f3e140785bf4249cd5cc73169b6ae32adb4a9d VASANI bf0b3e540264d5677d, pseudonym=4577cd45acbd4b81950fdca30f5e447f, 2.5.4.20=747c328d3a1e3225296efcb194cb6551268d2b7a972751d8213868e97966fe56, [email protected], cn=ATUL ARVIND VASANI Date: 2023.11.18 14:18:53 +05'30'

Atul Arvind Vasani Chairman & Managing Director

Place: Mumbai

==> picture [510 x 40] intentionally omitted <==

Earnings Conference Call Invite

==> picture [182 x 203] intentionally omitted <==

==> picture [77 x 88] intentionally omitted <==

==> picture [78 x 88] intentionally omitted <==

==> picture [60 x 55] intentionally omitted <==

Thursday, November 23, 2023

==> picture [59 x 55] intentionally omitted <==

Kirin Advisors Cordially invite you to the Q2 FY24 Earnings Call of Vaishali Pharma Limited

==> picture [158 x 192] intentionally omitted <==

04.00 PM

==> picture [99 x 64] intentionally omitted <==

==> picture [55 x 66] intentionally omitted <==

Joining Details Universal Dial In International Toll-Free Numbers Diamond Pass Login +91 22 6280 1239 USA : 18667462133 +91 22 7115 8140 UK : 08081011573 Singapore : 8001012045 Click Here To Register Hong Kong : 800964448

Note - When using dial-in numbers mentioned above please do so 10 minutes prior to the conference schedule to ensure that you are connected to your call in time.

==> picture [96 x 160] intentionally omitted <==

Speakers From Management

Mr. Atul Vasani – Chairman & Managing Director

Mr. Dewansh Vasani – Executive Director

Mr. Ratnesh Singh – Chief Financial Officer

==> picture [94 x 189] intentionally omitted <==

For More Information

==> picture [102 x 73] intentionally omitted <==

+91 22 4100 2455 +91 93244 75886

[email protected] www.kirinadvisors.com [email protected]

713-B Lodha Supremus II, Wagle Estate, Thane (W) 400 604.

Disclaimer - Certain statements that may be made or discussed at the conference call may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like significant changes in economic environment in India and abroad. Actual results might differ substantially from those expressed or implied. The company and its Management will not be in any way responsible for any action taken based on such statements and discussions.